Current Research Studies

An Observational Study of VYKATTM XR (Diazoxide Choline Extended-Release Tablets) in Patients with Prader-Willi Syndrome (PWS)

Soleno-C623

Phase: IV
Clinicaltrials.gov ID: NCT07450664

What is the goal of the study?

This is a prospective observational drug study developed to generate more evidence of the safety profile, clinical characteristics, and outcomes of patients with PWS treated with VYKAT XR in a real-world setting. The study will take place in the US. It is anticipated that approximately 200 patients will be enrolled and followed for up to 2 years in this observational study.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Melinda Pierce
Study Team Member: Adam Fiebelkorn, [email protected]